Medicare Enrolled

Dr. Adam Katz, M.D.

Ophthalmology · Vero Beach, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
3500 US HIGHWAY 1, Vero Beach, FL 32960
7722991404
In practice since 2005 (20 years)
NPI: 1790772101 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Katz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Katz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Katz

Dr. Adam Katz is an ophthalmology in Vero Beach, FL, with 20 years in practice. Based on federal Medicare data, Dr. Katz performed 18,328 Medicare services across 4,332 unique beneficiaries.

Between the years covered by Open Payments, Dr. Katz received a total of $15,227 from 39 pharmaceutical and/or device companies across 135 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Katz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 8% volume in FL$ $15,227 industry payments

Medicare Practice Summary

Medicare Utilization ↗
18,328
Medicare services
Top 8% in FL for ophthalmology
4,332
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~916 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Eye injection (Vabysmo/faricimab)10,440$29$45
Comprehensive eye exam, established patient3,642$88$256
Retinal imaging (OCT scan)2,782$30$82
Eye injection for retinal disease251$89$232
Comprehensive eye exam, new patient240$95$302
Extended exam of the back part of the eye with retinal drawing210$18$50
Office visit, established patient (30-39 min)202$95$264
Retinal photography (fundus photo)153$27$76
Office visit, established patient (20-29 min)142$67$186
Unclassified drugs79$245$469
Removal of eyelashes using forceps43$16$61
Visual field test, extended41$49$127
Removal of recurring cataract in lens capsule using a laser39$249$500
2d ultrasound scan of eye tissue and structures24$29$98
Optic nerve imaging (OCT scan)22$29$75
Office visit, established patient (10-19 min)18$33$116
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,227
Total received (2018-2024)
Avg $2,175/year across 7 years
Top 11% in FL for ophthalmology
39
Companies
135
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12,313 (80.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,914 (19.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$574
2023
$423
2022
$669
2021
$597
2020
$206
2019
$2,998
2018
$9,761

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Allergan Inc.
$12,313
Regeneron Healthcare Solutions, Inc.
$557
Novartis Pharmaceuticals Corporation
$260
Genentech USA, Inc.
$214
Johnson & Johnson Surgical Vision, Inc.
$205
Bausch & Lomb, a division of Bausch Health US, LLC
$201
ABBVIE INC.
$136
Alimera Sciences, Inc.
$131
Horizon Therapeutics plc
$107
Apellis Pharmaceuticals, Inc.
$96
Tarsus Pharmaceuticals, Inc.
$95
Omeros Corporation
$92
TOPCON MEDICAL SYSTEMS, INC.
$86
La Jolla Pharmaceutical Company
$63
Oyster Point Pharma, Inc.
$62
Bausch & Lomb Americas Inc.
$60
Rayner Intraocular Lenses Limited
$48
EyePoint Pharmaceuticals US, Inc.
$39
Kala Pharmaceuticals, Inc.
$38
Shire North American Group Inc
$35
Alcon Vision LLC
$29
Aerie Pharmaceuticals, Inc.
$27
Sight Sciences, Inc.
$26
SUN PHARMACEUTICAL INDUSTRIES INC.
$25
Alcon Laboratories Inc
$25
Ocular Therapeutix, Inc.
$25
PFIZER INC.
$24
Sun Pharmaceutical Industries Inc.
$23
Johnson & Johnson Vision Care, Inc.
$22
Harrow Eye, LLC
$21
Eyevance Pharmaceuticals LLC
$20
MERZ NORTH AMERICA, INC.
$19
Dompe US, Inc.
$19
Amgen Inc.
$17
Glaukos Corporation
$16
Electromed, Inc.
$14
TissueTech, Inc.
$14
RxSight Inc
$14
Allergan, Inc.
$12
Top 3 companies account for 86.2% of total payments
Associated products mentioned in payments ›
ACTIVEFOCUS · AcrySof IQ PanOptix · BOTOX · BOTOX THERAPEUTIC · CE-marked KXLA system · CEQUA · Cequa · DEXTENZA · DEXYCU · DOCTORS ALLERGY FORMULA · ENVISTA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Flarex · GIAPREZA · IHEEZO · ILUVIEN · INVELTYS · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LUMIGAN · Lucentis · NATRELLE · NURTEC ODT · OCT TRITON · OXERVATE · OZURDEX · Omidria · PROLENSA · Prokera · SMARTVEST · STELLARIS · STRATTICE · Syfovre · TEPEZZA · TYRVAYA · TearCare SmartLid · Tecnis 1-piece IOL · Tecnis IOL · Tecnis Simplicity · VABYSMO · VERITAS Vision System · VUITY · Vabysmo · XDEMVY · XIIDRA · YUTIQ · enVista MX60 IOL · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (81%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $83 per 100 Medicare services performed
Looking for a ophthalmology in Vero Beach?
Compare ophthalmologys in the Vero Beach area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologys nearby

Geographic Context

Ophthalmologys within 10 mi
27
Per 100K population
16.5
County median income
$71,049
Nearest hospital
CLEVELAND CLINIC INDIAN RIVER HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Katz is a mixed practice specialist, with above-average Medicare volume (top 8% in FL), and high industry engagement (speaking/promotional, top 11%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Katz experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Katz performed 10,440 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Katz receive payments from pharmaceutical companies?
Yes. Dr. Katz received a total of $15,227 from 39 companies across 135 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Katz's costs compare to other ophthalmologys in Vero Beach?
Dr. Katz's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Katz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →